Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?

Annals of Surgical Oncology

Volumn 12, Issue 9, 2005, Pages 712-717

  Degnim, Amy C ^a,b   Oh, Kevin ^a   Cimmino, Vincent M ^a   Diehl, Kathleen M ^a   Chang, Alfred E ^a   Newman, Lisa A ^a   Sabel, Michael S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Allergic reaction; Blue dye; Breast neoplasms; Sentinel lymph node biopsy

Indexed keywords

ISOSULFAN BLUE; ISOTOPE; TRACER;

BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR BIOPSY;

AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; MALE; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 23944508010     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2005.06.017     Document Type: Review

References (25)

1. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-6.
3. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
4. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
5. Tafra LC, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-9.
6. Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242-7.
7. Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 2002;184:341-5.
8. Sprung J, Tully MJ, Ziser A. Anaphylactic reactions to isosulfan blue dye during sentinel node lymphadenectomy for breast cancer. Anesth Analg 2003;96:1051-3.
9. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:966-78.
10. Schwartz GF, Guiliano AE, Veronesi U. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma of the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J 2002;8:124-38.
11. Grube BJ, Giuliano AE. Modification of the sentinel node technique: it was a hit in New York, but will it play in Poughkeepsie? Ann Surg Oncol 2001;8:3-6.
12. Cody HS, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13-9.
13. Goyal A, Mansel RE, Newcombe R. Relative value of blue dye and isotope in sentinel node localization for breast cancer in a multicenter trial. Eur J Cancer 2004; 3(Suppl 2):78.
14. DeRossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473-8.
15. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385-8.
16. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001;130:439-42.
17. Laurie SA, Khan DA, Gruchalla RS, et al. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2002;88:64-6.
18. Sadiq TS, Burns WW, Taber DJ, et al. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg 2001;136:1433-5.
19. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
20. McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000;231:724-31.
21. Layeeque R, Kepple J, Henry-Tillman RS, et al. Intraoperative subareolar injection for immediate sentinel lymph node biopsy. Ann Surg 2004;239:841-5.
22. Wu C, Morita ET, Treseler PA, et al. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J 2003;9:86-90.
23. Raut CP, Daley MD, Hunt KK, et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 2004;22:567-8.
24. King TA, Fey JV, Van Zee KJ, et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 2004;11:535-41.
25. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 2002;184:350-2.